A short, evidence-grounded conversation about SIRT1 and its place in longevity science.
Speaker 1
...and one of the most exciting molecules in longevity research right now is SIRT1. It's an NAD⁺-dependent deacetylase, a mouthful, but essentially, it's a longevity enzyme.
Speaker 2
Right, and the NAD⁺ connection is crucial. SIRT1 needs NAD⁺ as fuel to function. If NAD⁺ levels drop, SIRT1 can’t do its job, which is a big deal for cellular health.
Speaker 1
Exactly. Think of NAD⁺ as the gas in the tank for SIRT1. Without enough, this enzyme, which scientists are very interested in for its role in aging, just stalls.
Speaker 2
So, how do we get more active SIRT1? Caloric restriction has long been known to activate it, and that’s where compounds like resveratrol come in. It’s a classic SIRT1 activator, partly mimicking those caloric restriction effects, as shown in Nature in 2006.
Speaker 1
And then there’s its cousin, pterostilbene. It's a methylated resveratrol analog that also activates SIRT1, but with potentially better bioavailability, meaning more of it might reach the cells where it's needed.
Speaker 2
What’s still being actively researched, though, is the full extent of these compounds' effects in humans, and whether increasing SIRT1 activity directly translates to extended human lifespan or healthspan. That’s still very much an open question.
Speaker 1
Absolutely. But we do know that active SIRT1 promotes autophagy by deacetylating key autophagy proteins. Autophagy is that cellular 'housekeeping' process, clearing out damaged components, which is pretty fundamental to healthy aging.
Educational research discussion only — not medical advice. Statements have not been
evaluated by the FDA. Nothing here is intended to diagnose, treat, cure or prevent any disease.
Talk to a qualified clinician before changing any treatment.